advertisement
Abstract #58907 Published in IGR 16-3
Does government assistance improve utilization of eye care services by low-income individuals?
Hong CJ; Trope GE; Buys YM; Robinson BE; Jin YPCanadian Journal of Ophthalmology 2014; 49: 320-325
OBJECTIVE: To examine whether government-funded, low-income vision care programs improve use of eye care services by low-income individuals in Canada. DESIGN: Cross-sectional survey. PARTICIPANTS: 27,375 white respondents to the Canadian Community Health Survey (CCHS) Healthy Aging 2008/2009. METHODS: Government-funded, low-income vision care programs were reviewed. The amount of assistance provided was compared with professional fee schedules for general/routine eye examinations and market prices for eyeglasses. The utilization of eye care providers was derived from the CCHS. RESULTS: To receive low-income vision care assistance, individuals must be in receipt of social assistance. Criteria for receiving social assistance are stringent. The Canadian Financial Capability Survey revealed that 7.9% of Canadians aged 45 to 64 years and 5.5% aged ≥65 years received social assistance in 2009. The CCHS found in 2008/2009 that 12.5% of citizens aged 45 to 64 years and 13.2% of those aged ≥65 years had difficulty paying for basic expenses such as food. In 5 provinces, low-income vision care assistance fully covers a general/routine eye examination. In the remainder, the assistance provided is insufficient for a general/routine eye examination. The assistance for eyeglasses is inadequate in 5 provinces, requiring out-of-pocket copayments. Among middle-aged whites who self-reported not having glaucoma, cataracts, diabetes, or vision problems not corrected by lenses, utilization of eye care providers was 28.1% among those with financial difficulty versus 41.9% among those without (p < 0.05), giving a prevalence ratio 0.68 (95% CI 0.57-0.80) adjusted for age, sex and education. CONCLUSIONS: Despite government assistance, low-income individuals use vision care services less often than wealthy individuals.
Faculty of Medicine, University of Ottawa, Ottawa.
Full articleClassification:
14 Costing studies; pharmacoeconomics
